The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

The Analysis of relation to brain iron deposition of Parkinson's Disease using Quantitative Susceptibility Mapping

정량적 자화율 맵핑을 통한 뇌 철분 침착과 파킨슨병의 연관성 분석

  • Gyu-Ri Jeon (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Han-Gyul Lee (Department of Cardiology and Neurology of Korean Medicine, Kyung Hee University Medical Center) ;
  • Seung-won Kwon (Department of Cardiology and Neurology of Korean Medicine, Kyung Hee University Medical Center) ;
  • Seung-Yeon Cho (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Woo-Sang Jung (Department of Cardiology and Neurology of Korean Medicine, Kyung Hee University Medical Center) ;
  • Sang-Kwan Moon (Department of Cardiology and Neurology of Korean Medicine, Kyung Hee University Medical Center) ;
  • Jung-Mi Park (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Chang-Nam Ko (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong) ;
  • Seong-Uk Park (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong)
  • 전규리 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 이한결 (경희의료원 한방순환신경내과 ) ;
  • 권승원 (경희의료원 한방순환신경내과 ) ;
  • 조승연 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 정우상 (경희의료원 한방순환신경내과 ) ;
  • 문상관 (경희의료원 한방순환신경내과 ) ;
  • 박정미 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 고창남 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 박성욱 (강동경희대학교병원 뇌신경센터 한방내과)
  • Received : 2024.01.20
  • Accepted : 2024.02.16
  • Published : 2024.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study aimed to investigate the levels of brain iron deposition in Parkinson's disease (PD) patients using Quantitative Susceptibility Mapping (QSM) and to determine whether distinctions compared to the general population exist. Furthermore, we examined potential variations in iron deposition among different PD subtypes. Methods: Structural brain imaging was conducted on 75 participants at Gangdong Kyung Hee University Hospital between August 2017 and May 2020. PD patients were categorized into Tremor Dominant (TD) and Postural Instability and Gait Difficulty (PIGD) subtypes. Voxel-based morphometry and QSM were employed to compare voxel-wise magnetic susceptibility across the entire brain between Normal Controls (NC) and PD groups. Subsequently, QSM values were compared between TD and PIGD groups. Results: QSM values were compared among 46 PD patients and 23 normal controls, as well as between TD (n=22) and PIGD (n=24) groups. Voxel-based QSM analysis revealed no significant differences between groups. Similarly, ROI-based QSM analysis showed no significant distinctions. Conclusions: No significant variations were observed between the PD patient group, NC group, or PD subtypes. This study systematically compared QSM values across a broad range of brain regions potentially linked to PD pathology. Additionally, the subdivision of the PD group into TD and PIGD subtypes for QSM-based iron deposition analysis represents a meaningful and innovative approach.

Keywords

Acknowledgement

이 연구는 교육부의 한국연구재단을 통한 기초과학 연구 프로그램에서 지원받았습니다. (NRF-2017R1D1A1B03031688).

References

  1. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., & Seitelberger F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci, 20(4), 415-55. https://doi.org/10.1016/0022-510X(73)90175-5 
  2. Fearnley J. M., & Lees A. J. (1991). Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114(5), 2283-2301. https://doi.org/10.1093/brain/114.5.2283 
  3. de Rijk M. C., Rocca W. A., Anderson D. W., Melcon M. O., Breteler M. M., & Maraganore D. M.. (1997). A population perspective on diagnostic criteria for Parkinson's disease. Neurology, 48(5), 1277-81. https://doi.org/10.1212/WNL.48.5.1277 
  4. Deistung A., Schweser F., & Reichenbach J. R. (2017). Overview of quantitative susceptibility mapping. NMR Biomed, 30(4), e3569. https://doi.org/10.1002/nbm.3569 
  5. Haacke E. M., Liu S., Buch S., Zheng W., Wu D., & Ye Y. (2014). Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging, 33(1), 1-25. https://doi.org/10.1016/j.mri.2014.09.004 
  6. Ward R., Zucca F., Duyn J., Crichton R., & Zecca L. (2014). The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol, 13(10), 1045-60. https://doi.org/10.1016/S1474-4422(14)70117-6 
  7. Thenganatt M. A., & Jankovic J. (2014). Parkinson Disease Subtypes. JAMA Neurol, 71(4), 499-504. https://doi.org/10.1001/jamaneurol.2013.6233 
  8. Sethi K. (2008). Levodopa unresponsive symptoms in Parkinson disease. Mov Disord, 23(S3), 521-33. https://doi.org/10.1002/mds.22049 
  9. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbeet L., et al. (1990). Parkinson Study Group. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology, 40(10), 1529-34. https://doi.org/10.1212/WNL.40.10.1529 
  10. Rosenberg-Katz K., Herman T., Jacob Y., Giladi N., Hendler T., & Hausdorff J. M. (2013). Gray matter atrophy distinguishes between Parkinson disease motor subtypes. Neurology, 80(16), 1476-84. https://doi.org/10.1212/WNL.0b013e31828cfaa4 
  11. Calne D. B., Snow B. J., & Lee C. (1992). Criteria for diagnosing Parkinson's disease. Ann Neurol, 32(S1), 125-7. https://doi.org/10.1002/ana.410320721 
  12. Bagher-Ebadian H., Jiang Q., & Ewing J. R. (2008). A modified fourier-based phase unwrapping algorithm with an application to MRI venography. J Magn Reson Imaging, 27(3), 649-52. https://doi.org/10.1002/jmri.21230 
  13. Haacke E. M., Cheng N. Y., House M. J., Liu Q., Neelavalli J., Ogg R. J., et al. (2005). Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging, 23(1), 1-25. https://doi.org/10.1016/j.mri.2004.10.001 
  14. Braak H., Tredici K. D., Rub U., de Vos R. A., Jansen Steur E. N., & Braak E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 24(2), 197-211. https://doi.org/10.1016/S0197-4580(02)00065-9 
  15. Sian-Hulsmann J., Mandel S., Youdim M. B., & Riederer P. (2011). The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem, 118(6), 939-57. https://doi.org/10.1111/j.1471-4159.2010.07132.x 
  16. Uchida Y., Kan H., Sakurai K., Arai N., Kato D., Kawashima S., et al. (2019). Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment. Movement Disorders, 34(8), 1164-73. https://doi.org/10.1002/mds.27717 
  17. Deh K., Nguyen T. D., Eskreis-Winkler S., Prince M. R., Spincemaille P., Gauthier S., et al. (2015). Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J Magn Reson Imaging, 42(6), 1592-1600. https://doi.org/10.1002/jmri.24943 
  18. Ravanfar P., Loi S. M., Syeda W. T., Van Rheenen T. E., Bush A. I., Desmond P., et al. (2021). Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front. Neurosci, 15, 618435. https://doi.org/10.3389/fnins.2021.618435 
  19. Mazzucchi S., Frosini D., Costagli M., Del Prete E., Donatelli G., Cecchi P., et al. (2019). Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin, 24, 101999. https://doi.org/10.1016/j.nicl.2019.101999 
  20. Guan X., Xuan M., Gu Q., Xu X., Huang P., Wang N., et al. (2017). Influence of regional iron on the motor impairments of Parkinson's disease: a quantitative susceptibility mapping study. J Magn Reson Imaging, 45(5), 1335-42. https://doi.org/10.1002/jmri.25434 
  21. Alves G., Larsen J. P., Emre M., Wentzel-Larsen T., & Aarsland D. (2006). Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord., 21(8), 1123-30. https://doi.org/10.1002/mds.20897 
  22. Negre-Pages L., Grandjean H., Lapeyre-Mestre M., Montastruc J. L., Fourrier A., Lepine J. P., et al. (2010). Anxious and depressive symptoms in Parkinson's disease: the French cross -sectional DoPaMiP study. Mov Disord, 25(2), 157-66. https://doi.org/10.1002/mds.22760 
  23. Burn D. J., Landau S., Hindle J. V., Samuel M., Wilson K. C., Hurt C. S., et al. (2012). Parkinson's disease motor subtypes and mood. Mov Disord, 27(3), 379-86. https://doi.org/10.1002/mds.24041 
  24. Iijima M., Kobayakawa T., Saito S., Osawa M., Tsutsumi Y., Hashimotoet S., et al. (2011). Differences in odor identification among clinical subtypes of Parkinson's disease. Eur J Neurol, 18(3), 425-29. https://doi.org/10.1111/j.1468-1331.2010.03167.x 
  25. Moreau C., Delval A., Defebvre L., Dujardin K., Duhamel A., Petytet G. et al. (2012). Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol, 11(7), 589-96. https://doi.org/10.1016/S1474-4422(12)70106-0 
  26. Shahmaei V., Faeghi F., Mohammadbeigi A., Hashemi H., & Ashrafi F. (2019). Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping. European Journal of Radiology Open, 6, 169-74. https://doi.org/10.1016/j.ejro.2019.04.005 
  27. Chen Q., Chen Y., Zhang Y., Wang F., Yu H., Zhang C., et al. (2019). Iron deposition in Parkinson's disease by quantitative susceptibility mapping. BMC Neurosci, 20(23), 1-8. https://doi.org/10.1186/s12868-019-0505-9